The isolation of rare cells is critical in many research and clinical applications, where high purity is essential for accurate analysis and downstream processes. Currently used column-based methods often require multiple rinsing steps and involve a time consuming process, which may also affect the viability of the isolated cells. This application note introduces the new in situ rinse program. This workflow delivers the same high purity of rare cells as the traditional “serial program” and additionally significantly enhances throughput, allowing for the simultaneous processing of three samples. With faster processing times and increased automation, the MARS® platform streamlines the isolation of rare cells, ensuring rapid and reliable results.
New in situ rinsing program offers:
- High purity of rare cells ensuring reliable and accurate results
- High throughput – simultaneous processing of three samples
- Time-saving, fast processing times compared to traditional column-based methods
- Full automation minimizes manual handling
- High cell viability – streamlined isolation process helps to maintain the viability of isolated cells
- No columns, reusable tubing saving cost
